ISRCTN46778796已完成未知
Randomised Comparison of Cyclical Anthracycline-Based Chemotherapy [PA(BI)OE] with Alternating Chemotherapy [ChlVPP/PABIOE] in Advanced Hodgkin's Disease
British National Lymphoma Investigation (BNLI) (UK)0 个研究点目标入组 0 人开始时间: 2002年8月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. All previously untreated and properly staged patients aged between 15 and 69 years (inclusive) with Hodgkin's disease for whom chemotherapy is indicated are eligible for this trial, ie Stage I & IIA (poor prognosis), IB, IIB, III, IV
- •2. Patients must be free from any irreversible medical condition that would drastically limit their life span or prohibit the use of combination chemotherapy. This applies particularly to elderly patients
- •3. Adequate long term follow-up must be possible
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
不适用
Randomised comparison of cyclical anthracyline-based chemotherapy [PA(B1)OE] with alternating chemotherapy [Ch1VPP/PABLOE] in advanced Hodgkin's diseaseCancerISRCTN63499520Cancer Research UK (CRUK) (UK)
已完成
3 期
Randomized study of anthracycline vs. TS-1 in patients with metastatic or recurrent breast cancerMetastatic or recurrent breast cancerJPRN-UMIN000005449SELECT BC-CONFIRM executive committee200
已完成
2 期
A feasibility study of sequential Anthracycline-based regimen and Nab-Paclitaxel / Trastuzumab followed by Trastuzumab as postoperative adjuvant chemotherapy for Her2 positive breast cancer.(SBCCSG-22)Primary breast cancerJPRN-UMIN000006085Saitama Breast Cancer Clinical Study Group(SBCCSG)30
Unknown
2 期
Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast CancerBreast NeoplasmsAdjuvantChemotherapyNCT00525642Fudan University603
已完成
2 期
A feasibility study of Anthracycline-based regimen followed by Nab-Paclitaxel as adjuvant chemotherapy for breast cancer.(SBCCSG-32)Primary breast cancerJPRN-UMIN000012428Saitama Breast Cancer Clinical Study Group(SBCCSG)40